deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT01500161

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

A Phase II Study Of Pooled Unrelated Donor Umbilical Cord Blood (UCB) Transplant For Patients With Hematologic Malignancies Needing Allogeneic Stem Cell Transplant But Do Not Have A Related HLA-Matched Donor

Sponsor: Texas Oncology Cancer Center

Conditions Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Aplastic Anemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hodgkins Disease Multiple Myeloma Myelodysplastic Syndrome Non-Hodgkins Lymphoma
Interventions Busulfan Carmustine Clofarabine Cytarabine Etoposide Fludarabine Melphalan
Updated 5 times since 2017 Last updated: Nov 21, 2013 Started: Nov 30, 2011 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insufficient accruals

Other Acute Lymphocytic Leukemia trials with similar outcome

Browse all Acute Lymphocytic Leukemia trials

Listed as NCT01500161, this PHASE2 trial focuses on Acute Lymphocytic Leukemia and Acute Myelogenous Leukemia and remains terminated or withdrawn. Sponsored by Texas Oncology Cancer Center, it has been updated 5 times since 2011, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE2

    First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Texas Oncology Cancer Center
Data source: Texas Oncology Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations